Citicoline in Ophthalmological Neurodegenerative Disease: A Comprehensive Review
Cytidine 5’-diphosphocholine has been widely studied in systemic neurodegenerative diseases, like Alzheimer’s disease, Parkinson’s disease, and brain ischemia. The rationale for the use of citicoline in ophthalmological neurodegenerative diseases, including glaucoma, anterior ischemic optic neuropat...
Main Authors: | Francesco Oddone, Luca Rossetti, Mariacristina Parravano, Diego Sbardella, Massimo Coletta, Lucia Ziccardi, Gloria Roberti, Carmela Carnevale, Dario Romano, Gianluca Manni, Vincenzo Parisi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/3/281 |
Similar Items
-
Cytidine 5′-Diphosphocholine (Citicoline) in Glaucoma: Rationale of Its Use, Current Evidence and Future Perspectives
by: Gloria Roberti, et al.
Published: (2015-11-01) -
Cytidine 5′-Diphosphocholine (Citicoline): Evidence for a Neuroprotective Role in Glaucoma
by: Stefano Gandolfi, et al.
Published: (2020-03-01) -
Commentary: Citicoline: A Food Beneficial for Patients Suffering from or Threated with Glaucoma.
by: Vincenzo Parisi, et al.
Published: (2016-08-01) -
The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives
by: Gareri P, et al.
Published: (2015-09-01) -
INJECTED CITICOLINE IMPROVES IMPAIRMENT AND DISABILITY DURING ACUTE PHASE TREATMENT IN ISCHEMIC STROKE PATIENTS
by: Rino Wahyudi, et al.
Published: (2016-11-01)